Skip to main content
. Author manuscript; available in PMC: 2010 Apr 26.
Published in final edited form as: Proteomics. 2009 May;9(9):2468–2483. doi: 10.1002/pmic.200800613

Figure 4.

Figure 4

Apolipoprotein C-III in LDL. (Left) The 2-DE analysis (n = 5) revealed a significant increase in apolipoprotein C-III in LDL with exercise treatment compared to all other treatment groups (C, H, and DD). The F-ratio was highest in the 2-DE experiment. (Middle) LFQMS analysis (n = 4) and SRM (Right) revealed no significant increases in apolipoprotein C-III with any treatment group. * Denotes a significant difference compared to control (C) animals; # denotes a significant difference from hyperlipidemic (H) animals; †denotes a significant difference compared to diabetic dyslipidemic (DD) animals (p ≤0.01).